WDR4 and hepatocellular carcinoma: Ming Kuang et al. demonstrated that m7G methyltransferase complex protein methyltransferase-like 1 (METTL1) and WD repeat domain 4 (WDR4) promoted Lenvatinib resistance in hepatocellular carcinoma by increasing the translation of EGFR pathway genes [16].